The merger of RestorGenex Corp. and Diffusion Pharmaceuticals LLC, closed on Jan. 8, created an oncology-focused clinical-stage company with a diversified development portfolio of product candidates addressing novel targets, including several orphan indications. The combined company, named Diffusion Pharmaceuticals Inc., is now headquartered in Charlottesville, Virginia.